Tag Archives: Applied DNA Sciences

Maxim Group Keeps Their Hold Rating on Applied DNA Sciences (APDN)

Maxim Group analyst Anthony Vendetti maintained a Hold rating on Applied DNA Sciences (APDN – Research Report) yesterday. The company’s shares closed last Monday at $0.28, close to its 52-week low of $0.25. Vendetti observed: “Yesterday, after the Market close,

Maxim Group Keeps a Hold Rating on Applied DNA Sciences (APDN)

Maxim Group analyst Anthony Vendetti maintained a Hold rating on Applied DNA Sciences (APDN – Research Report) yesterday. The company’s shares opened today at $0.59. Vendetti commented: “2019, APDN announced that its cannabis partner, TheraCann International (private), secured an agreement

Maxim Group Thinks Applied DNA Sciences’ Stock is Going to Recover

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Applied DNA Sciences (NASDAQ: APDN) today and set a price target of $3. The company’s shares closed yesterday at $1.18, close to its 52-week low of $1.10. Vendetti commented: “Market

Maxim Group Maintains a Buy Rating on Applied DNA Sciences

Maxim Group analyst Brian Kinstlinger maintained a Buy rating on Applied DNA Sciences (NASDAQ: APDN) today and set a price target of $5. The company’s shares closed yesterday at $1.52. Kinstlinger said: “While we expect cotton to generate the majority

Applied DNA Sciences Receives a Buy from Maxim Group

Maxim Group analyst Brian Kinstlinger reiterated a Buy rating on Applied DNA Sciences (NASDAQ: APDN) today and set a price target of $5. The company’s shares opened today at $1.70. Kinstlinger observed: “APDN announced a two-year, $1 million contract with

Applied DNA Sciences Gets a Buy Rating from Maxim Group

Maxim Group analyst Brian Kinstlinger reiterated a Buy rating on Applied DNA Sciences (NASDAQ: APDN) today and set a price target of $5. The company’s shares closed yesterday at $2.30. Kinstlinger commented: “According to APDN’s latest investor deck filed on